These findings augment the established NF2–Merlin and Hippo pathway alterations in convexity meningiomas by describing an alternative oncogenic pathway with enrichment in skull base and non-NF2 tumors with a significant predilection for progesterone receptor-positive tumors. The gene discussed is NF2; the disease is meningioma.